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Abstract  
Introduction: Hepatocellular carcinoma (HCC) is the most common primary tumour of the liver. It mostly 
metastasise to lungs, followed by abdominal lymph nodes and bones. However, cutaneous metastases of 
HCC are very rare, accounting for 0.2% to 2.7% of all cutaneous metastases. The most common location is 
the head (usually the face), followed by the chest, the abdomen, and the limbs, but metastasis to back is 
very uncommon. 
Presentation of Case: A 63 year old man presented with history of mild fatigue and right upper abdominal 
pain for two months and a swelling in the back for 15 days. He was diagnosed with hepatocellular 
carcinoma. With biopsy and immunohistochemistry, it was confirmed that the swelling in the back was a 
cutaneous metastasis from hepatocellular carcinoma, which is very rare. 
Conclusion: Because cutaneous metastases are a very uncommon manifestation of HCC and metastasis to 
back is even more rare, the present case should increase awareness of their existence. 
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Introduction 
Hepatocellular carcinoma (HCC) is the most common primary tumour of the liver. It is 
predominantly found in men 50-60 years of age, and is most commonly due to cirrhosis secondary 
to alcoholism, viral Hepatitis B or C, haemochromatosis, or autoimmune diseases. 
  Hepatocellular carcinoma metastasizes via blood, direct spread, or lymphatic dissemination. 
Extrahepatic metastasis of HCC has been reported in advanced disease, such as stage III and IV. In 
such cases, distant metastases occur from the primary site in the liver through the portal vein to the 
lungs most predominantly (55%), followed by abdominal lymph nodes (41%) and bones (28%) [1]. 
However, cutaneous metastases of HCC are very rare, accounting for 0.2% to 2.7% of all cutaneous 
metastases [2]. The most common location is the head (usually the face), followed by the chest, the 
abdomen, and the limbs [3], but metastasis to back is very uncommon. 
  Herein, we report a case of hepatocellular carcinoma with a cutaneous swelling in the back 
which on investigation was found to be metastasis from HCC. 
Case History 
A 63 year old man presented in May 2014 with history of mild fatigue and right upper abdominal 
pain for two months and a swelling in the back for 15 days. On clinical examination, there was 
hepatomegaly. The swelling in the back measured about 4cmx4cm [Figure 1]. It was soft in 
consistency, non tender and free from underlying structures. The skin over the swelling was normal. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1 Clinical photograph of the patient with back lesion 
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Routine blood tests were carried out. Hemoglobin level was 12 g/dl (normal 13-17 g/dl), TLC and 
DLC and platelet count were within normal limits. Total bilirubin was 0.8 mg/dl (normal upto 1 
mg/dl), SGPT - 73 U/L, SGOT - 140 U/L and Alkaline phosphatase - 675 U/L. His 
carcinoembryonic antigen (CEA) tumour marker level was 1.7 ng/ml (normal upto 3 ng/ml in non 
smokers) and alpha fetoprotein (AFP) was >1000 IU/ml (normal - 5.8 IU/ml). HBsAg test was 
positive, but HCV and HIV tests were negative. Computed tomography (CT) of the abdomen 
showed a large heterogenous space occupying lesion (SOL) of size 11 cm x 11 cm in the right lobe 
of the liver and a small hypodense lesion of size 2 cm x 2.4 cm in the left lobe [Figure 2]. Both the 
lesions had heterogenous enhancement. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2 CT scan showing liver SOL 
FNAC from the liver SOL showed clusters and discrete atypical cells having nucleomegaly, 
clumped chromatin, prominent nucleoli and abundant amount of cytoplasm which were consistent 
with hepatocellular carcinoma. Trucut biopsy from the swelling in the back revealed cutaneous 
metastasis from hepatocellular carcinoma [Figure 3]. The tumour cells were positive for CD10 and 
TTF-1 [Figure 4a & 4b]  but negative for AFP, CD15, CEA and EMA. 
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Figure 3 Histopathology of Trucut biopsy from back lesion ((haematoxylin-eosin stain 40 X) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4a  Tumor cells positive for CD 10 
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Figure 4b Tumor cells positive for TTF-1 
 
  In consideration of the disease stage (metastatic) and the patient’s clinical status (Eastern 
Cooperative Oncology Group [ECOG] 1 - Child A), treatment with Sorafenib (800 mg/day) was 
carried out. 
  The patient is under follow-up and there is no increase in size of the lesion after two months of 
initiation of therapy. 
Discussion 
HCC is the most common primary malignant tumor of the liver, and its incidence has increased in 
recent years. It is predominantly found in men 50-60 years of age, and is most commonly due to 
cirrhosis secondary to alcoholism, viral Hepatitis B or C, haemochromatosis, or autoimmune 
diseases. 
  Hepatocellular carcinoma metastasizes via blood, direct spread, or lymphatic dissemination. 
Extrahepatic metastasis of HCC has been reported in advanced disease, such as stage III and IV. In 
such cases, distant metastases occur from the primary site in the liver through the portal vein to the 
lungs most predominantly (55%), followed by abdominal lymph nodes (41%) and bones (28%) [1]. 
However, cutaneous metastases of HCC are very rare, accounting for 0.2% to 2.7% of all cutaneous 
metastases [2]. These metastases can be the first manifestation of the primary tumor or, the first 
sign of disease recurrence [4]. Histopathological examination of the skin metastasis may reveal the 
identity of the primary tumor. 
  Cutaneous metastasis of HCC occurs most frequently in men over 50 years of age, usually in the sixth 
decade of life, and usually manifests as a single painless, fast-growing lesion. The most common 
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location is the head (usually the face), followed by the chest, the abdomen, and the limbs [3]. But 
this patient had metastasis to back which is very rare.  
  The lesions can take a variety of clinical forms but are usually firm, bluish-red or purple, 1 to 5 
cm in diameter, and nonulcerated [2-5]. They may also be necrotic or purulent or resemble 
pyogenic granulomas [6]. 
  Three different mechanisms by which a liver tumor can produce cutaneous metastases have been 
described: continuous growth from the liver parenchyma, systemic spread of disease, and tumor 
implantation or seeding following manipulation of the lesion using various diagnostic or 
therapeutic methods [7]. 
  Histopathologic diagnosis is possible when a hepatocellular component-bile production in part of 
the tumor, intercellular bile canaliculi, or a trabecular growth pattern-is present [3]. From an 
immunohistochemical perspective, Hepatocyte paraffin 1 (HepPar-1), CD10, CEA and TTF-1 have 
proved to be very helpful in the diagnosis of poorly differentiated tumors [8,9]. In this patient, 
positivity of tumor cells for CD10 and TTF-1 helped us to reach the diagnosis. 
  The presence of cutaneous metastases of HCC is associated with a very poor prognosis, an 
increased likelihood of metastases at other sites, and a median survival of less than 5 months 
[10,11]. In this case the patient is surviving after two months of treatment with Sorafanib and is on 
regular follow-up. 
Conclusion 
Because cutaneous metastases are a very uncommon manifestation of HCC and metastasis to back 
is even more rare, the present case should increase awareness of their existence. The possibility of 
skin metastasis should be considered in HCC patients who present with skin lesions, and the 
diagnosis should be confirmed by biopsy. 
Consent 
The patient has given his informed consent regarding publication of his case.  
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